| 2026-03-12 |
详情>>
股本变动：
变动后总股本9750.00万股
|
| 2026-03-12 |
详情>>
业绩披露：
2025年年报每股收益-1.78美元,归母净利润-1.28亿美元,同比去年增长-225.49%
|
| 2026-03-12 |
财报披露：
美东时间 2026-03-12 盘后发布财报
|
| 2026-02-26 |
详情>>
内部人交易：
CONTINENZA JAMES V共交易2笔
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.55美元,归母净利润-2000万美元,同比去年增长-126.32%
|
| 2025-08-11 |
详情>>
业绩披露：
2025年中报每股收益-0.48美元,归母净利润-3300万美元,同比去年增长-156.9%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.12美元,归母净利润-700万美元,同比去年增长-121.88%
|
| 2025-04-10 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.Election of the seven director nominees named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm.
4.Such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-03-17 |
详情>>
业绩披露：
2024年年报每股收益0.97美元,归母净利润1.02亿美元,同比去年增长36.00%
|
| 2025-03-17 |
详情>>
业绩披露：
2022年年报每股收益0.16美元,归母净利润2600.00万美元,同比去年增长8.33%
|
| 2024-11-25 |
复牌提示：
2024-11-25 08:53:00 停牌，复牌日期 2024-11-25 09:33:06
|
| 2024-11-12 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.68美元,归母净利润7000.00万美元,同比去年增长268.42%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.73美元,归母净利润7600.00万美元,同比去年增长8.57%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益0.56美元,归母净利润5800.00万美元,同比去年增长-14.71%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益0.31美元,归母净利润3200.00万美元,同比去年增长-3.03%
|
| 2024-04-05 |
股东大会：
将于2024-05-15召开股东大会
会议内容 ▼▲
- 1.Election of the seven director nominees named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Approval of the Second Amendment to the Amended and Restated 2013 Omnibus Incentive Plan.
4.Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm.
5.Such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-03-14 |
详情>>
业绩披露：
2023年年报每股收益0.71美元,归母净利润7500.00万美元,同比去年增长188.46%
|
| 2023-04-05 |
股东大会：
将于2023-05-17召开股东大会
会议内容 ▼▲
- 1.Election of the seven director nominees named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm.
4.Such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-04-06 |
股东大会：
将于2022-05-18召开股东大会
会议内容 ▼▲
- 1.Election of the seven director nominees named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm.
4.Such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-09 |
股东大会：
将于2021-05-19召开股东大会
会议内容 ▼▲
- 1.Election of the seven director nominees named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Approval of the First Amendment to the Amended and Restated 2013 Omnibus Incentive Plan.
4.Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm.
5.Such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-04-09 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.Election of the seven directors named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Advisory vote on the frequency (once every one, two or three years) of future advisory votes on the compensation of our named executive officers.
4.Approval of the Amendment and Restatement of the Company’s 2013 Omnibus Incentive Plan.
5.Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm.
6.Such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2019-04-09 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.Election of the seven directors named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Ratification of the Audit and Finance Committee’s selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
4.Such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2018-04-09 |
股东大会：
将于2018-05-22召开股东大会
会议内容 ▼▲
- 1. Election of the nine directors named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2. Advisory vote to approve the compensation of our named executive officers.
3. Vote to approve the First Amendment to the 2013 Omnibus Incentive Plan.
4. Ratification of the Audit and Finance Committee’s selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
5. Such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2017-04-10 |
股东大会：
将于2017-05-23召开股东大会
会议内容 ▼▲
- 1.Election of the nine directors named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Ratification of the Audit and Finance Committee’s selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
4.Such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2016-04-11 |
股东大会：
将于2016-05-24召开股东大会
会议内容 ▼▲
- 1.Election of the nine directors named in the Proxy Statement for a term of one year or until their successors are duly elected and qualified.
2.Advisory vote to approve the compensation of our named executive officers.
3.Ratification of the Audit and Finance Committee’s selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
4.Such other business as may properly come before the Annual Meeting or any adjournment thereof.
|